Titan Pharmaceuticals (NASDAQ:TTNP) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report released on Monday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance TTNP stock opened at $0.33 on Monday. The company has a 50 day moving average price of $0.35 and a […]
More Stories
Trump Signs ‘Big, Beautiful Bill’ Into Law During July 4 Celebration
By Emel Akan WASHINGTON—President Donald Trump signed the One Big Beautiful Bill Act into law on July 4, celebrating both...
Hurricanes Land Last Big-Name Free Agent in Nik Ehlers
By Matthew Davis The Carolina Hurricanes made one of the biggest signings of the NHL offseason on Thursday by landing...
Federal Reserve Rates Are Too High, Says Former World Bank Chief
By Naveen Athrappully Former World Bank President David Malpass criticized the U.S. Federal Reserve for keeping its benchmark interest rate...
Fall For Me: Netflix’s Erotic Thriller Premieres August 2025
Netflix is all set to welcome an epic German erotic thriller, Fall For Me, that is sure to make the...
Independence Day: A Reflection on the Past, A Warning for the Future
By Stephen Zogopoulos, USNN World News The Meaning of Independence Day: Then and Now Every July 4th, Americans gather to...
8tshare6a Software Download Guide: Features, Safety, and Alternatives
There are numerous software programs available online for various purposes, some of which are useful and some of which are...